Amalgamated Bank lifted its stake in shares of Xylem Inc. (NYSE:XYL – Free Report) by 0.6% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 47,559 shares of the industrial products company’s stock after acquiring an additional 289 shares during the period. Amalgamated Bank’s holdings in Xylem were worth $6,152,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also modified their holdings of XYL. Allspring Global Investments Holdings LLC raised its holdings in shares of Xylem by 468.7% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 72,665 shares of the industrial products company’s stock worth $8,711,000 after acquiring an additional 59,888 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd raised its holdings in shares of Xylem by 2.1% during the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 28,406 shares of the industrial products company’s stock worth $3,393,000 after acquiring an additional 586 shares during the period. Aaron Wealth Advisors LLC purchased a new position in shares of Xylem during the 1st quarter worth $232,000. Teacher Retirement System of Texas raised its holdings in shares of Xylem by 1,462.5% during the 1st quarter. Teacher Retirement System of Texas now owns 35,516 shares of the industrial products company’s stock worth $4,243,000 after acquiring an additional 33,243 shares during the period. Finally, Resonant Capital Advisors LLC raised its holdings in shares of Xylem by 4.8% during the 1st quarter. Resonant Capital Advisors LLC now owns 2,387 shares of the industrial products company’s stock worth $285,000 after acquiring an additional 110 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Stock Down 0.3%
Shares of NYSE:XYL opened at $151.00 on Friday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.43. The firm has a market capitalization of $36.76 billion, a PE ratio of 38.82, a price-to-earnings-growth ratio of 2.50 and a beta of 1.13. The firm’s 50-day moving average is $144.74 and its two-hundred day moving average is $134.21. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $154.27.
Xylem Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were paid a dividend of $0.40 per share. The ex-dividend date was Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem’s dividend payout ratio is 41.13%.
Insider Transactions at Xylem
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the sale, the chief accounting officer directly owned 2,957 shares in the company, valued at $413,861.72. This represents a 25.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Claudia S. Toussaint sold 10,421 shares of the company’s stock in a transaction that occurred on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the sale, the executive vice president owned 31,250 shares in the company, valued at $4,770,000. The trade was a 25.01% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.27% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. Stifel Nicolaus raised their price objective on Xylem from $175.00 to $178.00 and gave the stock a “buy” rating in a research report on Wednesday. Robert W. Baird set a $178.00 price objective on Xylem in a research report on Wednesday. Barclays raised their price objective on Xylem from $165.00 to $172.00 and gave the stock an “overweight” rating in a research report on Wednesday. Weiss Ratings reissued a “buy (b)” rating on shares of Xylem in a research report on Wednesday, October 8th. Finally, Cowen reissued a “hold” rating on shares of Xylem in a research report on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $166.20.
Read Our Latest Report on Xylem
Xylem Company Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also
- Five stocks we like better than Xylem
- What is the Dow Jones Industrial Average (DJIA)?
- Amazon Earnings: 3 Catalysts That Could Drive Shares to $300
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Why Chipotle Stock May Bounce After a Brutal Sell-Off
- Profitably Trade Stocks at 52-Week Highs
- Why VGT May Be a Smarter Bet Than Chasing Individual Tech Stocks
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
